PDPN and neoplasm: Podoplanin, the only established endogenous ligand for CLEC-2, is described on the surface of tumors or lymphatic endothelial cells and stimulates platelet activation through CLEC-2 binding to promote blood-borne tumor metastasis or the separation of blood/lymphatic vessels at the developmental stage [12].